Sodium ferric gluconate complex

Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.[1] The macromolecule has an apparent molecular weight of 289,000 – 440,000 Dalton.[2]

Sodium ferric gluconate complex
Clinical data
Trade namesFerrlecit
AHFS/Drugs.comMonograph
MedlinePlusa614030
License data
Routes of
administration		Intravenous (IV)
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC66H121Fe2NaO65
Molar mass2089.309 g·mol−1
3D model (JSmol)

The most common side effects in adults are nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain.[1] In children the most common side effects are hypotension, headache, hypertension, tachycardia and vomiting.[1]

References
  1. "Ferrlecit- sodium ferric gluconate complex injection". DailyMed. 25 September 2019. Retrieved 2 April 2020.
  2. http://www.drugbank.ca/drugs/DB09517, retrieved 2020-Jun-21


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.